The long term goal of the proposed research is to understand the molecular mechanisms underlying motor nerve terminal differentiation. Regulated differentiation of nerve terminals is essential for the formation of appropriate connections in the developing nervous system. One important signal leading to terminal differentiation appears to come from the extracellular matrix protein agrin, previously known as an inducer of postsynaptic differentiation. Agrin can induce selective adhesion of motor neurons, inhibit outgrowth of motor neurites, and promote clustering of synaptic vesicles; these properties are expected of a presynaptic inducer. Inhibition of agrin function, in vivo or in vitro, leads to a failure of presynaptic differentiation. The proposed research is designed to answer several questions about agrin's role in presynaptic differentiation. First, how does agrin regulate motor neurons' growth and differentiation. The activities of neural vs. muscle agrin on motor neurons will be compared using transfected muscle cells and transgenic mice. Ca2+ signals induced in motor neurons by agrin will be characterized, and the relationship between these signals and agrin's activities will be examined. Second, what domains of agrin are required for interactions with neurons? Agrin isoforms and fragments will be used to determine the structural basis of agrin's actions on neurons. Finally, what are the neuronal receptors for agrin? The binding properties and localization of neuronal agrin binding proteins will be characterized, as a first step in the identification of functionally relevant neuronal agrin receptors. Additionally, the potential for various cell adhesion molecules to act as agrin receptors will be examined. The proposed experiments will provide key information concerning the mechanisms underlying nerve terminal formation by focusing on agrin, the single best candidate for a target-derived inducer of presynaptic differentiation. Information about the molecular basis of synaptogenesis may be useful in the diagnosis and treatment of developmental disorders of the brain and spinal cord. In addition, these results will bear on the mechanism of regeneration after nervous system injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS036773-03
Application #
6188011
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Leblanc, Gabrielle G
Project Start
1998-04-06
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
3
Fiscal Year
2000
Total Cost
$204,577
Indirect Cost
Name
University of Miami School of Medicine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Baerwald-de la Torre, Kristine; Winzen, Uwe; Halfter, Willi et al. (2004) Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin. J Neurochem 90:50-61
Bixby, John L; Baerwald-De la Torre, Kristine; Wang, Cong et al. (2002) A neuronal inhibitory domain in the N-terminal half of agrin. J Neurobiol 50:164-79
Dimitropoulou, A; Bixby, J L (2000) Regulation of retinal neurite growth by alterations in MAPK/ERK kinase (MEK) activity. Brain Res 858:205-14